FDA-Labeled Indications for Chronic Weight Management As of early 2026, two medications carry FDA indications specifically for chronic weight management in adults: Wegovy (semaglutide 2.4 mg) approved 2021 Zepbound (tirzepatide) approved 2023 Liraglutide (Saxenda) is also approved for weight management but has been largely supplanted by the once-weekly options
Patients exercised regularly and followed a reduced-calorie diet
Prefer fully remote medical care - A telehealth-only model may appeal to individuals with limited time, transportation challenges, or a preference for privacy and convenience
Your insurance might not cover Rybelsus for weight loss, but this oral medication delivers semaglutide efficiently, facilitating weight loss
Most make some version of the same promise: support the pathways associated with prescription GLP-1 medications, but without a prescription
Add a sprinkle of chia seeds and a serving of low-fat Greek yogurt